We help hospitals and health systems uncover financial opportunities that are frequently overlooked.
By identifying low- or no-cost, high-ROI initiatives that deliver meaningful financial and operational value, we help hospitals strengthen financial performance, improve efficiency, and preserve patient care.
Operating-margin and revenue-cycle performance partner for small-to-medium and rural hospitals. Conducts at-risk RCM and non-labor expense assessments and delivers an average
3–5% net revenue lift via charge capture optimization (ChargeView) and real-time RCM analytics (ExpressView). Engagements are performance-based, requiring no upfront
client capital or IT bandwidth.
Cost: Performance-based; no upfront capital
Friction: Low — no IT lift; assessment-led entry
Value: 3–5% net revenue lift on average
Capital-backed execution partner for stalled, high-impact revenue cycle and financial performance initiatives. Capta funds and executes the work alongside the health system, taking on the risk and earning compensation only on measurable improvement. Joint-venture-style model preserves governance, culture, and autonomy while extending E2E-level capability.
Cost: Capital-backed; paid on measurable improvement
Friction: Low — JV-style; preserves governance and culture
Value: Unlocks stalled high-impact RCM and finance initiatives
National Auditing Services & Consulting — cost-recovery and utility-bill auditing firm specializing in identifying overbillings and reducing future spend across electric, gas, water/sewer, steam, oil, propane, telecom/wireless, and real estate property tax invoices. Operates on a contingency model —
clients pay only a share of recovered refunds and realized savings, with refunds available etroactively up to five years.
Cost: Contingency only — share of recovered refunds and savings
Friction: Very low — NASC works from existing utility/tax invoices
Value: Retro refunds up to 5 years + reduced future utility spend
Alternative funding partner providing fast, flexible working capital to healthcare providers by advancing funds against private and government insurance receivables. Functions as accounts-receivable factoring — DML purchases the medical claim, advances cash to the provider, and reassigns the account once the payer settles, allowing the provider to retain any patient-pay balance. Operates since 2014 with one-time, revolving, and tailored facility structures.
Cost: Factoring discount on advanced claims; no traditional debt
Friction: Low — off-balance-sheet; works for distressed/restructuring practices
Value: Fast working capital without bank financing
Cleveland-based national group purchasing organization (formerly CHAMPS GPO) with 28,000+ member locations and $1.5B in collective spend. Partners with Premier and OMNIA
Partners to deliver competitive pricing across med/surg, pharmacy, foodservice, IT, wireless, office, and facility categories. Known for high-touch account management and aggregation through Capstone Health Alliance.
Cost: GPO membership; no fee to provider on most categories
Friction: Low — layers onto existing supply chain operations
Value: Premier-tier pricing across med/surg, pharmacy, and indirect spend
Cost-reduction specialist focused on medical device reprocessing and strategic material management for hospitals and Ambulatory Surgical Centers. Helps providers reclaim,
reprocess, and reintegrate single-use and reusable supplies to lower per-procedure cost and reduce reliance on new purchases.
Cost: Net savings per procedure; pricing tied to reprocessed device use
Friction: Low — plugs into OR and central supply workflow
Value: Material lower per-procedure device cost in OR/ASC settings
Clinical-grade automation that streamlines payer interactions, prior authorizations, and coverage compliance at the point of care. Reduces phone calls (78% in cited deployments), cuts bad debt by an average of 48%, and frees nurses and physicians from administrative work so they can focus on
patients.
Cost: SaaS/automation pricing; ROI driven by bad-debt reduction
Friction: Low — deploys at point-of-care without EMR replacement
Value: 78% fewer payer calls; 48% avg. bad-debt reduction
AI-powered claims-denial remediation platform (“Daniel”) that uses machine learning to analyze denied claims, identify root causes, correct errors in real time, and auto-resubmit to payers. Delivered as Outcome-as-a-Service — Red Sky is paid only on revenue actually recovered, aligning incentives with the provider’s bottom line.
Cost: Outcome-as-a-Service — paid only on revenue recovered
Friction: Low — layers on top of existing 837/835 workflow
Value: Recovers cash from previously written-off denials
Comprehensive pharmacy management and Direct Pharmacy Care (DPC) partner for healthcare organizations. Wellyfe develops, manages, and markets entity-owned community pharmacies, and provides pharmacy consulting that optimizes operations, staffing, and clinical quality. By disintermediating traditional pharmacy benefit channels, Wellyfe helps health systems lower drug spend, capture pharmacy margin, and deliver localized, equitable pharmacy care.
Cost: Management-fee or shared-savings on pharmacy P&L
Friction: Moderate — stands up entity-owned pharmacy or restructures existing
Value: Captured pharmacy margin + lower drug spend + community access
Many hospitals and health systems may be entitled to recover significant tariff-related costs that were passed through by suppliers—and most organizations are unaware the opportunity exists.
Recent court rulings have challenged the legality of certain IEEPA tariffs, creating potential refund opportunities for organizations that ultimately absorbed tariff-related cost increases.
Pivot Health Advisors identifies, quantifies, and recovers tariff-related overpayments on a contingency basis—with no upfront cost and minimal burden on your team.
While hospitals often purchased affected products through distributors, GPO contracts, and suppliers rather than importing directly, those tariff costs were frequently embedded in the prices they paid. As a result, hospitals may have incurred millions of dollars in tariff-related overpayments without realizing there may be a path to recovery.
How the Process Works
Our team conducts a comprehensive review of:
Using data from February 2024 through February 2026, we identify tariff-related cost increases, quantify the potential recovery opportunity, and develop a strategy for reimbursement.
Once the opportunity is validated, we engage suppliers directly on behalf of the health system to seek voluntary repayment of overcharges. Our goal is to recover funds through a collaborative, good-faith process whenever possible.
If a supplier declines to provide reimbursement and the client chooses to proceed, we work with experienced legal counsel to pursue recovery through appropriate legal channels. All litigation costs are advanced by our team and are recovered only from settlement proceeds.
No Upfront Cost
Our engagement is entirely contingency-based.
Voluntary Supplier Reimbursement
25% of recovered funds
Recovery Requiring Legal Action 40% of recovered fundsIf no funds are recovered, there is no fee.